News

Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies

Featured Posts

Capstan Therapeutics Begins Phase 1 Trial of CAR-T Therapy for Autoimmune Disease 

Capstan Therapeutics, a biotechnology company spun out of Penn, has initiated its Phase 1 trial of an in vivo CAR-T therapy.

REGENXBIO’s Gene Therapy Updates for Hunter Syndrome and DMD 

REGENXBIO was co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.

Penn Startup Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform

Vivodyne was co-founded by Dan Huh, PhD, Professor of Bioengineering in Penn Engineering and CEO Andrei Georgescu.,

Research at Penn Report Highlights the Global Impact of Penn’s Research 

Penn has over 5,000 research faculty spanning 200+ centers.

Philadelphia Ranks #13 Globally, Climbing Up 12 Spots, in 2025 Global Startup Ecosystem Report

The 2025 Global Startup Ecosystem Report has been released.

Penn Engineering Hosts “AI at the Crossroads: Ethics, Innovation & Impact” During Philly Tech Week  

Melissa Kelly, PhD, Deputy Managing Director of PCI, served as a panelist and shared her insights on the impact of AI.

PCI Celebrates Philly Tech Week by Hosting “Innovate & Inspire: Research Panel & Pitch Competition”  

The 15th annual Philly Tech Week took place from May 5 - 10, 2025, with the goal of celebrating innovation and empowering startups in the region’s thriving tech ecosystem. 

2025/2026 PCI Fellows Cohort Announced   

The PCI Fellows program is an internship opportunity in technology commercialization that is open to graduate students, postdoctoral fellows and junior research staff at Penn.

Three Penn I-Corps Teams Participated in State-wide Pitch Event 

Three Penn I-Corps teams participated in the SmartTech Tournament on April 10 and 11, 2025 as part of the Invent Penn State Venture & IP Conference.

Penn I-Corps Spring 2025 Cohort Concludes Successfully

PCI is delighted to announce graduation of its Spring 2025 Penn I-Corps cohort, which comprised ten teams drawn from participants across Penn.  

Filter

Success Stories

Highlights of the PCI news focused on Penn commercialization accomplishments

All Success Stories